156 related articles for article (PubMed ID: 7756662)
21. Phosphoglycolate phosphatase and 2,3-diphosphoglycerate in red cells of normal and anemic subjects.
Somoza R; Beutler E
Blood; 1983 Oct; 62(4):750-3. PubMed ID: 6309283
[TBL] [Abstract][Full Text] [Related]
22. Postnatal regulation of 2,3-DPG in sheep erythrocytes.
Mueggler PA; Carpenter S; Black JA
Am J Physiol; 1983 Sep; 245(3):H506-12. PubMed ID: 6311032
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of erythrocyte sickling in vitro by pyridoxal.
Kark JA; Kale MP; Tarassoff PG; Woods M; Lessin LS
J Clin Invest; 1978 Oct; 62(4):888-91. PubMed ID: 701485
[TBL] [Abstract][Full Text] [Related]
24. Modification of sickle hemoglobin by acetaldehyde and its effect on oxygenation, gelation and sickling.
Abraham EC; Stallings M; Abraham A; Garbutt GJ
Biochim Biophys Acta; 1982 Jul; 705(1):76-81. PubMed ID: 7115734
[TBL] [Abstract][Full Text] [Related]
25. High pyruvate kinase activity causes low concentration of 2,3-diphosphoglycerate in fetal rabbit red cells.
Jelkmann W; Bauer C
Pflugers Arch; 1978 Jul; 375(2):189-95. PubMed ID: 29278
[TBL] [Abstract][Full Text] [Related]
26. How do sickle cells become dehydrated?
Merciris P; Giraud F
Hematol J; 2001; 2(3):200-5. PubMed ID: 11920246
[No Abstract] [Full Text] [Related]
27. Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies.
Lu L; Li Z; Li H; Li X; Vekilov PG; Karniadakis GE
Sci Adv; 2019 Aug; 5(8):eaax3905. PubMed ID: 31457104
[TBL] [Abstract][Full Text] [Related]
28. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
[TBL] [Abstract][Full Text] [Related]
29. A procedure for decreasing the level of 2,3-bisphosphoglycerate in red cells in vitro.
Rose ZB
Biochem Biophys Res Commun; 1976 Dec; 73(4):1011-7. PubMed ID: 15625875
[TBL] [Abstract][Full Text] [Related]
30. Sickling-suppressive effects of chrysin may be associated with sequestration of deoxy-haemoglobin, 2,3-bisphosphoglycerate mutase, alteration of redox homeostasis and functional chemistry of sickle erythrocytes.
Muhammad A; Waziri AD; Forcados GE; Sanusi B; Sani H; Malami I; Abubakar IB; Muhammad A; Muhammad RA; Mohammed HA
Hum Exp Toxicol; 2020 Apr; 39(4):537-546. PubMed ID: 31876182
[TBL] [Abstract][Full Text] [Related]
31. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Devlin MT; Schwartz E
Biochim Biophys Acta; 1981 May; 668(3):397-405. PubMed ID: 7236716
[TBL] [Abstract][Full Text] [Related]
32. Determination of deoxyhemoglobin S polymer in sickle erythrocytes upon deoxygenation.
Noguchi CT; Torchia DA; Schechter AN
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5487-91. PubMed ID: 6933568
[TBL] [Abstract][Full Text] [Related]
33. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
Berkowitz LR; Orringer EP
Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
[TBL] [Abstract][Full Text] [Related]
34. Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
Rab MAE; van Oirschot BA; Bos J; Merkx TH; van Wesel ACW; Abdulmalik O; Safo MK; Versluijs BA; Houwing ME; Cnossen MH; Riedl J; Schutgens REG; Pasterkamp G; Bartels M; van Beers EJ; van Wijk R
Am J Hematol; 2019 May; 94(5):575-584. PubMed ID: 30784099
[TBL] [Abstract][Full Text] [Related]
35. Studies on a large kindred with hemolytic anemia and low erythrocyte 2,3-DPG.
Harkness DR; Roth S; Goldman P; Kim C; Isaacks RE
Prog Clin Biol Res; 1978; 21():251-74. PubMed ID: 208085
[No Abstract] [Full Text] [Related]
36. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes.
Brittenham GM; Schechter AN; Noguchi CT
Blood; 1985 Jan; 65(1):183-9. PubMed ID: 3965046
[TBL] [Abstract][Full Text] [Related]
37. Oxygen transport in congenital heart disease: influence of fetal hemoglobin, red cell pH, and 2,3-diphosphoglycerate.
Versmold HT; Linderkamp C; Döhlemann C; Riegel KP
Pediatr Res; 1976 Jun; 10(6):566-70. PubMed ID: 5699
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the gelation of extracellular and intracellular hemoglobin S by selective acetylation with methyl acetyl phosphate.
Ueno H; Benjamin LJ; Pospischil MA; Manning JM
Biochemistry; 1987 Jun; 26(11):3125-9. PubMed ID: 3607016
[TBL] [Abstract][Full Text] [Related]
39. Activation of human erythrocyte 2,3-bisphosphoglycerate phosphatase at physiological concentrations of substrate.
Reynolds CH
Arch Biochem Biophys; 1986 Oct; 250(1):106-11. PubMed ID: 3021059
[TBL] [Abstract][Full Text] [Related]
40. The molecular basis of antisickling agents.
Franklin IM; Huehns ER
Trans R Soc Trop Med Hyg; 1980; 74(6):695-700. PubMed ID: 7210123
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
